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The Genetic Activity Profile Database
by Michael D. Waters,* H. FrankStack,t Neil E.
Garrett,t and Marcus A. Jacksont
Agraphicapproachtermed aGeneticActivityProfile(GAP) hasbeendevelopedtodisplayamatrixofdataonthegenetic
and related effects ofselected chemical agents. The profiles provide a visual overview ofthe quantitative (doses) and
qualitative (test results) dataforeachchemical. Eitherthelowesteffectivedose (LED) orhighest ineffective dose (HID)
isrecordedforeachagentandbioassay. Upto200differenttestsystemsarerepresentedacrosstheGAP. Bioassaysystems
areorganized according tothe phylogeny ofthe testorganisms and theend pointsofgenetic activity. Themethodology
fortheproductionandevaluationofGAPshasbeendevelopedincolaboration withtheInternational AgencyforResearch
onCancer. Dataonindividualchemicals havebeencompiledby LARC andby theU.S. Environmental Protection Agen-
cy. Dataareavailableon299compoundsselectedfromvolumes1-50oftheLARCMonogmphsandon 115compoundsiden-
tifiedasSuperfundPrioritySubstances. SoftwaretodisplaytheGAPsonanIBM-compatiblepersonalcomputerisavailable
fromthe authors.
StructurallysimilarcompoundsfrequentlydisplayqualitativelyandquantitativelysimilarGAPs. Byeamning the pat-
ternsofGAPsofpairsandgroupsofchemicals, itispossibletomakemoreinformeddecisionsregardingtheselectionof
test batteries tobeused inevaluatingchemicalanalogs. GAPshaveprovided useful dataforthedevelopment ofweight-
of-evidencehazardrankingschemes. Also,someknowledgeofthepotentialgeneticactivityofcomple environmentalmix-
turesmaybegainedfromassessingtheGAPsofcomponentchemicals. Thefundamentaltechniquesandcomputer pro-
grams devised for the GAPdatabase may be used to developsimilar databases in other disciplines.
Introduction
Dataderived from short-term tests areusually interpreted ac-
cording tothephylogenetic category ofthe testandtheendpoint
detected. Commonly studiedendpoints include DNAdamage,
gene mutation, sister chromatid exchange, micronuclei, chro-
mosomalaberrations, aneuploidy, andcell transformation. Few
short-termbioassays monitor morethan one or twooftheseend
points. Therefore, data from a varietyofshort-termtests are re-
quired toproperly define the responseprofileofagivenchemical
agent.
Garrett et al. (1) developed a technique for presenting the
quantitative genetictoxicology datafor achemicalcompound as
abargraph (genetic activity profile) inwhich test systems (iden-
tifiedby three-letter codewords) aredisplayed along theX-axis,
and values corresponding to thedosesemployed inthe tests are
shown ontheY-axis. Thetotaldataavailable from upto200dif-
ferent short-term bioassays for a compound are thus presented
in a standardized format that allows rapid visualization ofthe
genetic (or related) effects induced. The technique facilitates
qualitative aswell asquantitative assessments ofgenetic toxici-
ty. Current procedures for preparing and evaluating Genetic
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Activity Profiles (GAPs)aredescribedbyWatersetal. (2) inthe
contextoftheiruseby theInternational Agency forResearch on
Cancer.
Methodology
Thedata setforagivenchemical, consistingofadiscrete set
oftestsandthedosesrequiredtoinduceresponsesinthosetests,
arepresentedinabargraphillustrated inFigure 1. Thebars (pro-
file lines) originating onthe X-axis representthetestsplotted in
eitheraphylogenetic orendpointsequence. Athree-lettercode
isusedtoidentifythetestsystemrepresentedbyeachbar. Values
onthe Y-axis arethe logarithmically transformed lowesteffec-
tivedoses (LED) andhighestineffectivedoses (HID) tested. The
term "dose," asused inthisreport, does nottakeintoconsidera-
tion length oftreatment or exposure and may therefore be con-
sidered synonymouswithconcentration. Thedosesorconcen-
trationsusedforallin vitro testswereconvertedtomicrograms
per milliliter and those for in vivo tests to milligrams per
kilogrambody weightperday. Becausedoseunitsareplottedon
a log scale, differences inmolecular weights ofcompounds do
not greatly influence comparisons oftheir GAPs.
Profile-lineheight(themagnitudeofeachbar) isafunctionof
theLEDorHID, which isassociatedwiththecharacteristics of
each individual test system, such as population size, cell-cycle
kinetics, andmetabolic competence. Thus, thedetection limitof
each test system isdifferent, and across agivenGAP, responses
will vary substantially. No attempt is made to adjust or relate
responses in one test system to those ofanother.WATERS ETAL.
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FIGURE 1. A schematic representation of a genetic activity profile showing
four studies forthe test ECW (two positive and two negative). The average
logarithmic doseunitofthemajoritycall isindicatedby asolidvertical bar.
Adashedvertical barindicatesconflicting test results forthe study. Note in
cases wherethere are anequal numberofpositiveandnegativestudies ashere,
the majority call is positive.
Lineheights arederived as follows: Fornegative testresults,
thehighestdosetested withoutexcessivetoxicity isdefined asthe
HID. Ifthere isevidenceofextreme toxicity, the nextlowerdose
is used. A single dose tested yielding a negative result is con-
sidered equivalent to the HID. For positive results, the LED is
recorded. Iftheoriginal datahavebeenanalyzed statistically by
the author, the dose recorded is that at which the response was
significant (p < 0.05). Ifthedata were notanalyzed statistical-
ly, thedoserequired toproduce aneffect isestimated asfollows:
When adose-related positive response is observed with two or
moredoses, the lowerofthedoses istaken astheLED; asingle
dose resulting in apositive response isconsideredequivalent to
the LED.
To accommodate both positive and negative responses on a
continuous scale, doses are transformed logarithmically sothat
effective (LED) and ineffective (HID)doses are represented by
positive and negative numbers, respectively. The logarithmic
dose unit (LDUij) for a given test system i and chemicalj is
represented by the expressions:
LDUiJ =-logl0(dose), for HID values; LDU < 0
LDUiJ = 5-logI0(dose), for LED values; LDU > 0
These simple relationships define a dose range of 0 to -5
logarithmic units for ineffective doses (1-100,000 ,ug/mL or
mg/kg body weight) and0 to +9 logarithmic units foreffective
doses (100,000-0.0001 pglmL ormg/kgbodyweight). Ascale il-
lustrating the LDU values is shown in Figure 1. Negative re-
sponses atdoses lessthan 1 pg/mL(mg/kgbody weight) are set
equal to 1. Effectively, anLEDvalue > 100,000 oran HIDvalue
< 1 produces anLDU =0; noquantitative information isgained
from such extremevalues. Levelsoflogdoseunitsbetween 1 and
-1 define a "zone ofuncertainty" inwhichpositive results are
reported at very high doses (10,000-100,000 1g/mL or mg/kg
body weight), andnegative results arereported atrelatively low
dose levels (1-10lAg/mL or mg/kg body weight).
All dose values areplotted foreach assayusingeither abar (-)
for results obtained in the absence of an exogenous metabolic
system or a caret(A) forthoseobtained inthe presenceofan ex-
ogenousmetabolic system. Whenallresultsforagivenassayare
eitherpositiveornegative, thegeometric meanoftheresponses
isplottedasa solid line; whenconflicting dataare reported for
the sameassay (i.e., bothpositiveandnegativeresults), thema-
joritydataareshownwithasolidlineandtheminoritydatawith
adashedline(drawntotheextremeresponse). Inthefewcases
wherethenumbersofpositiveandnegativeresultsareequal, the
solid line is drawn in the positive direction, and the negative
response is indicated withadashed line, drawn fromtheorigin
to the extreme negative LDU.
Thethree-lettercodewordsrepresenting thecommonly used
testswereoriginallydefinedbytheGene-ToxProgramoftheU.S.
EnvironmentalProtectionAgency(EPA)(3,4). Thesecodeshave
been systematically redefined and expanded in a manner that
should facilitate inclusion ofadditional tests in the future (2).
Evaluation ofGenetic and
Related Effects
TheInternationalAgencyforResearchonCancer(IARC)has
employed the GAP methodology (2) in evaluating genetic and
relatedeffectsofsuspectedhumancarcinogens inIARCMono-
graphs, supplement6(5)andinvolumes 36, 39, 41,44 (13-16)
and 46-50 (6-10). Table 1 illustrates the procedure currently
employed by the IARC as itrelates to the GAP database.
Nesnow(personalcommunication)hasrecentlycompleteda
PC D-Base version ofthedata on carcinogenicity contained in
IARCMonographs, supplement7(17) andIARCMonographs,
volumes 43 (18), 44 (16), 45 (19), and 46-49 (6-9). Most of
these agents are included in the GAP database [derived from
IARC Monographs, supplement 6 (5) and volumes 46-50
(6-10)]. Therefore, thesetwodatabases canbeused toexamine
retrospectively theusefulnessofshort-termtests forthepredic-
tion of carcinogenicity and the relationship between specific
genetic end points or assays and carcinogenicity.
PersonalComputerVersionoftheGAP
Database, Version 3.0
Copiesofsoftware forIBM-compatible personal computers to
display and search GAPs are available from the authors. Com-
puterprograms requirethefollowingminimumconfiguration:
PC usingIntel 8086chip(PC XT) with640kbmemory, ahard
diskdrive, an enhanced graphics card (EGA or VGA), a high-
resolution colormonitor, and DOS version 3.2 orhigher.
TIble 1. Currentprocessofchemical selectionandreviewofdataongenetic
and related effects usedto prepare genetic activity profiles for
IARCMonographs.
Before the IARCMonograph working group meeting
1. IARC selects compounds andcompletes literature search
2. Working subgroupmembers reviewliteratureforindividualcompound(s)
3. Subgroup member prepares written summary, summarytable, and data
listing, drafts are sentto IARC
During the IARCMonograph group meeting
4. Genetic and related effects subgroup convenes
5. Data summaries and tests are verified foreach compound
6. Final drafts are submitted to working group for review
7. Datatablesand summariesare senttoEPA/GeneticToxicology Divisionfor
dose verification
8. Genetic activity profiles and data listings areprepared and sent to IARC
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Generally, an Intel 80286 (PC AT) computer is preferred
becausedataprocessing andgraphicsdisplay arefasterthanwith
the 8086computer. Optional devices usedfordataandgraphic
output include a line printer and plotter. Alternatively, a laser
printerorequivalentcanbeusedtoprinttheHPGLplotterfiles
using additional software.
The GAP software is distributed on three double-sided,
double-density, 5.25-inch floppy disks; the program disk, the
datadisk, andtheGAPbibliography. Executableprograms are
archivedontheprogramdiskandarecompiled fromprograms
writteninTurboPascal. Duringinstallationoftheprograms, the
necessarydirectory andsubdirectories arecreated. Theinstalled
programs anddata use approximately 1.2 Mbofdisk space.
Thebibliography ofthe GAPdataisalso in anarchived file.
Thefilerequires 0.7 Mbofdiskspace; however, thebibliography
is not necessary to operate the GAP programs, and it may be
deleted and reinstalled as needed.
The data disk consists oftwo data sets, [ARC and EPA. The
IARC data setcontainsdataon299agentspublishedinsupple-
ment 6 (5) and in volumes 46-50 of the IARC Monographs
(6-10). TheEPAdatasetcontainsdataon 115 agentsassembled
fortheGeneticToxicology DivisionoftheU.S. Environmental
ProtectionAgency (11). Alistoftheindividualprojectsinclud-
edineachdatasetmaybeviewedusingtheGAPcomputerpro-
gram. Adatasubdirectoryisprovidedforuserstoentertheirown
data.
Main Program Menu
ThemainprogrammenuofGAPversion3.0offersthefollow-
ing selections: agents, profiles, datalistings, modifydata, short
citations, andadditionalinformation. "Agents"providesoptions
to list the available projects, CAS numbers, and agent names.
Anothermenuallowsorderingofthelistbyanyofthethreeop-
tions. "Profiles" providesgraphicdisplay oftheshort-termtest
dataonselectedagents. Amenuisusedtoselectthesequenceof
testcodes, either inphylogenetic orderoforganisms(i.e., pro-
karyotes, lowereukaryotes, etc.)orintestendpointorder(i.e.,
DNA damage, gene mutation, etc.). Individual testcodes may
beexaminedtodeterminethesourcecitationsbyusingtheGAP
program zoom-in features.
"Listings" producesalistingofthedataineitherphylogenetic
or end point order and may be directed to the PC screen, to a
printer, ortoadatafile. "Modifydata" is used toadd, change,
or delete agents or test results (test codes, results, doses, and
reference numbers).
"ShortCitations" permitssearchingtheliteraturecitationin-
formationforapproximately 6000shortcitationscontainedinthe
GAP database. The citation information includes the citation
number (LITNR), the Environmental Mutagen Information
Center (EMIC) accession number, and a short citation (con-
sisting ofthe last names ofup to three authors, the first page
numberandtheyearofthepublication). Thecitationinforma-
tionmaybesearchedbyauthororbyEMICnumbertodetermine
ifacitation is present. Shortcitationsalso may beadded tothe
file and areautomatically assigned citation numbers.
"Additional information" includesthree-letter testcodedefini-
tions, thescaleoflog-doseunitsusedintheprofiles, information
onthedoseconversions, andtables listingprojectsforboththe
EPA and IARC data sets.
SomeApplicationsoftheGAPDatabase
ComparativeEvaluation ofGeneticActivity
ProflesUsingComputer-BasedProflle-Matching
Techniques
Whereanadequate numberofthe sametests havebeenused
toevaluatetwoormorechemicals, itispossibletousethemain-
frame computer to select matching pairs ofGAPs. This com-
puter-based pairwise matching process may be extended to all
chemicals in the database. The pilot applications ofthis pro-
cedure to EPA databases on known or suspected human car-
cinogens(I)andonpesticidechemicals(12)havedemonstrated
that structurally similar compounds frequently display
qualitatively andquantitatively similarprofilesofgeneticactivi-
ty. ThisimpliesthattheGAPdatabaseshouldbeofconsiderable
utilityinstructure-activity relationshipinvestigationsandintest
battery selection (20).
By examining the patterns of GAPs of pairs and groups of
chemicals, itispossibletomakemoreinformeddecisionsregar-
ding the selection oftestbatteries to be used in thesubsequent
evaluationofstructurally similarchemicals. Theapproachdraws
onallinformationwithinthedatabaseandmaybelinkedtocom-
puter systems that model the molecular properties of the
chemicalsunderevaluation (21). Thiscomparativeinformation
can enhance our understanding of the relationships between
geneticandrelatedactivityinshort-termtestsandmolecularpro-
perties ofstructurally related chemicals andthuscontribute to
ourknowledgeofthemechanismsofcomplexprocessessuchas
carcinogenesis.
TestingandEvaluatingComplexMixtures
ArecentapplicationofGAPsisintestingandevaluatingcom-
plexmixtures (22). Someknowledgeofthepotentialgenetic ac-
tivityofacomplexenvironmentalmixturemaybegainedfrom
assessingthegeneticactivityofitscomponentchemicals. This
requiresinformationonthechemicalcomponentsandcomposi-
tion ofthe mixture. For example, the Atmospheric Chemical
Compounddatabasedevelopedby Graedel etal. (23) contains
information on chemical structures, properties, detection
methods, and sources ofchemicals found in ambient air. The
GAPdatabaseprovidesacomputer-generatedgraphicrepresen-
tation ofgenetic bioassay dataas a function ofdose. Using the
two databases, information on the quantity of an individual
chemicalpresentwithinamixturemayberelatedtothequanti-
ty (LED) ofthe chemical required to demonstrate a positive
responseinoneormoregeneticbioassays. Quantitativeinforma-
tiononthecarcinogenic potency ofeach individual compound
(TD5ovalue) may also be related to the quantity present in the
mixtureormixturefraction. Inturn, thequantityofthechemical
in the complex mixture to which humans are exposed may be
estimated and used to calculate the percent human exposure
dose/rodent potency dose (HERP) for the chemical (24-26).
Using an additivity assumption, for example, an estimate of
potentialcarcinogenichazardforthemixturemaybecalculated
basedontheHERPindicesfortheknownchemicalcomponents.
This conceptual approach is limited by the relatively small
numberofchemicalsidentifiedincomplexmixturesforwhich
genetic toxicology andanimal cancerdataexist.
4344 WATERS ETAL.
Weight-of-Evidence Ranking Schemes
Committee 1 oftheInternationalCommissionforProtection
Against Environmental MutagensandCarcinogens (ICPEMC)
has for several years been involved in the development of a
computer-basedmethodology toassesstheevidencefromshort-
term genetic tests that a chemical is a mutagen (27). The
evaluativeapproachselectedbyICPEMC Committee 1 isbased
on a '"weighted test" scoring system that provides a relative
ranking of genotoxic potential. Input data for this ranking
methodology have been obtained from the GAP database
describedabove(28). TheresultsoftheapplicationoftheCom-
mittee 1 ranking scheme are to be compared by ICPEMC to
resultsobtainedbyapplyingthecarcinogenicity rankingscheme
ofNesnow (29,30).
DevelopmentofOtherDatabases
Thefundamental techniquesandcomputerprogramsdevised
fortheGAPdatabasemaybeusedtodevelopsimilardatabases
in genetic toxicology and in other disciplines. Dearfield et al.
(31)havedescribedtheapplicationoftheGAPmethodologyto
the databasebeing constructed by the EPA Office ofPesticide
Programs. Kavlock et al. (32) have successfully used the ap-
proachandmodifiedcomputerprogramstoassemblegraphicac-
tivity profiles and corresponding data listings for several de-
velopmental toxicants.
Future Directions
AusefulapplicationoftheGAPdatabaseinthefuturewillin-
volvecomputer-based profile-matching techniqueswithweight-
of-evidenceranking schemestocreateasubsetofchemicalsthat
act similarly, i.e., have similar GAPs. Correlative structure-
activityapproachescanthenbeusedmoreeffectivelytoidentify
thesubstructuralelementsofchemicals thatareresponsible for
particular biological responses so as to suggest biologically
plausiblemechanisms ofaction (33).
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